Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Parameter</td><td align="center">Clinical outcome</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">ACPR</td><td align="center">92.53% (161)</td></tr><tr><td align="left">ETF</td><td align="center">0.60% (01)</td></tr><tr><td align="left">LCF</td><td align="center">03.45% (06)</td></tr><tr><td align="left">LPF</td><td align="center">03.45% (06)</td></tr><tr><td align="left"><b>Clinical treatment failure</b></td><td align="center"><b>07.50% (13)</b></td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Clinical outcome of patients attending CAMEF during the <i>in vivo</i> study, 2007-2008 after treatment with Malartin and SP.

Journal of Tropical Medicine

tab2

Table 2

Table 2: Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon 

Table 2 | Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon 